⌘K

Login Start Free

Home/Filings/4/0000899243-22-024004

4//SEC Filing

Biondi Paul 4

Accession 0000899243-22-024004

CIK 0001609809other

View on SEC.gov Company Profile

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:35 PM ET

Size

5.4 KB

Accession

0000899243-22-024004

Insider Transaction Report

Form 4

Period: 2022-06-22

Seres Therapeutics, Inc.MCRB

Director

Transactions

Award
Stock Option (right to buy)
2022-06-22+35,000→ 35,000 total
Exercise: $3.22Exp: 2032-06-21→ Common Stock (35,000 underlying)

Footnotes (1)

[F1]The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeother

Related Parties

1

filerCIK 0001744508

Filing Metadata

Form type: 4
Filed: Jun 23, 8:00 PM ET
Accepted: Jun 24, 4:35 PM ET
Size: 5.4 KB

View on SEC.gov